The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Biologic responses to weight loss and weight regain: report from an American Diabetes Association research symposium.
Abstract
On 26–28 April 2013, the American Diabetes Association convened an international group of experts in Washington, DC, for a research symposium titled “Biologic Responses to Weight Loss and Weight Regain.” The speakers addressed the following topics: 1 ) developmental processes and the prevention of weight gain, 2 ) behavioral management approaches to weight loss, 3 ) distinctions between the physiological mechanisms of weight loss and weight maintenance and the implications for treatment, 4 ) the role of exercise in weight loss and maintenance, 5 ) the physiological mechanisms and effectiveness of bariatric surgery, and 6 ) pharmacological approaches to weight loss and maintenance. Both scientific and clinical perspectives were provided. The meeting concluded with an open session in which all the participants discussed emerging areas of investigation as well as unmet research needs. This discussion resulted in a series of recommendations for future research directions (Table 1). This Perspective article consists of summaries of the symposium sessions, by topic. View this table: Table 1 Recommendations for research questions regarding biologic responses to weight loss and weight regain The rapid increase in the prevalence of childhood obesity has drawn attention to early life influences that may, in part, explain the increased susceptibility to weight gain for individuals and populations. This session featured investigators examining gestational factors and events early in intra- and extrauterine development that may predispose individuals to obesity later in life, such as the programming of the body weight “set point.” These investigations may uncover developmental stages where behavioral or clinical interventions could be implemented to prevent or minimize excessive weight gain. A propensity toward obesity may begin in utero. Over 40 studies have found a U-shaped relationship between birth weight and the risk for a variety of illnesses, including obesity, type 2 diabetes, and cardiovascular disease, with both high and low birth weights associated with greater risk. Susan Ozanne …
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Larger-than-expected reductions in resting and nonresting energy expenditure that occur with weight loss (ie, metabolic adaptation), compensatory changes in other homeostatic regulators of body weight, and patients' behavioral fatigue in adhering to diet and activity recommendations may contribute to the 5% to 10% weight reduction plateau observed with behavioral therapy.[23][24][25]”
In the citing paper
“Maintaining long-term weight loss is challenging because of metabolic adaptation 2 and the difficulty of adhering to lifestyle interventions, 3 with weight regain often following weight loss.4”
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“When germ-free genetically obese mice or those obese due to a high-fat diet are colonized with microbiota from a lean donor they gain less weight than those colonized with microbes from an obese donor (87), suggesting that gut microbiota can influence adiposity.”
BackgroundA PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Predicting Obesity in Young Adulthood from Childhood and Parental Obesity
Whitaker, R. C., Wright, J. A., Pepe, M. S., Seidel, K. D., & Dietz, W. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709253371301 · Cited by 4,397
Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes
Schauer, P. R., Kashyap, S. R., Wolski, K., Brethauer, S. A., Kirwan, J. P., Pothier, C. E., Thomas, S., Abood, B., Nissen, S. E., & Bhatt, D. L. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200225 · Cited by 2,164
Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
Shai, I., Schwarzfuchs, D., Henkin, Y., Shahar, D. R., Witkow, S., Greenberg, I., Golan, R., Fraser, D., Bolotin, A., Vardi, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708681 · Cited by 2,143
Changes in Energy Expenditure Resulting from Altered Body Weight
Leibel, R. L., Rosenbaum, M., & Hirsch, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321001 · Cited by 2,012 · cited 1×
“Set-point theories suggest that maintaining a lower body weight is difficult because body weight is regulated at a predetermined level (or range) by altering energy expenditure and intake via a variety of feedback control mechanisms (8).”
BackgroundSelf-citationComparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates
Sacks, F. M., Bray, G. A., Carey, V. J., Smith, S. R., Ryan, D. H., Anton, S. D., McManus, K., Champagne, C. M., Bishop, L. M., Laranjo, N., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804748 · Cited by 1,966
Self-citationWing, R. R., Lang, W., Wadden, T. A., Safford, M., Knowler, W. C., Bertoni, A. G., Hill, J. O., Brancati, F. L., Peters, A., Wagenknecht, L., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2415 · Cited by 1,828
Bariatric Surgery and Long-term Cardiovascular Events
Sjöström, L., Peltonen, M., Jacobson, P., Sjöström, C. D., Karason, K., Wedel, H., Ahlin, S., Anveden, Å., Bengtsson, C., Bergmark, G., et al. (2012) · JAMA · doi:10.1001/jama.2011.1914 · Cited by 1,656 · cited 1×
“control group at 10 years), were also associated with the surgical interventions (24,67).”
BackgroundMeta-Analysis: Surgical Treatment of Obesity
Maggard, M. A., Shugarman, L. R., Suttorp, M., Maglione, M., Sugerman, H. J., Livingston, E. H., Nguyen, N. T., Li, Z., Mojica, W. A., Hilton, L., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00013 · Cited by 1,567 · cited 1×
“Duodenal switch, though more technically challenging than RYGB, may result in even greater weight loss (70).”
BackgroundHeymsfield, S. B., Greenberg, A. S., Fujioka, K., Dixon, R. M., Kushner, R., Hunt, T., Lubina, J. A., Patane, J., Self, B., Hunt, P., et al. (1999) · JAMA · doi:10.1001/jama.282.16.1568 · Cited by 1,422 · cited 1×
“The hormone leptin, for example, is not an effective weight-loss medication in humans, even at very high doses (111), but can normalize energy expenditure and ingestive behaviors at very low doses in weight-reduced humans (53).”
BackgroundLong-term weight-loss maintenance: a meta-analysis of US studies
Anderson, J. W., Konz, E. C., Frederich, R. C., & Wood, C. L. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.5.579 · Cited by 1,351 · cited 2×
“After successful weight loss in a structured program, people on average regain 80% of the lost weight within 5 years (34) (Fig.”
BackgroundThe Body-Mass Index of Twins Who Have Been Reared Apart
Stunkard, A. J., Harris, J. R., Pedersen, N. L., & McClearn, G. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005243222102 · Cited by 1,286 · cited 1×
“Genetic factors clearly play an important role, as evidenced by studies of twin pairs that indicate 70% of the variance associated with BMI is heritable (9).”
BackgroundPetrovic, N., Walden, T. B., Shabalina, I. G., Timmons, J. A., Cannon, B., & Nedergaard, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.053942 · Cited by 1,263 · cited 1×
“Thiazolidinediones (TZDs), such as rosiglitazone, induce “browning” in white fat, as indicated by an increase in uncoupling protein 1 (UCP1), a marker of brown fat, both in vitro and in vivo (112,113).”
BackgroundTrophic Action of Leptin on Hypothalamic Neurons That Regulate Feeding
Bouret, S. G., Draper, S. J., & Simerly, R. B. (2004) · Science · doi:10.1126/science.1095004 · Cited by 1,218 · cited 1×
“For example, leptin is neurotrophic in vitro, and leptin-deficient mice show altered patterns of synapses in hypothalamic proopiomelanocortin neurons that are involved in appetite regulation (6).”
BackgroundLiu, S., Willett, W. C., Stampfer, M. J., Hu, F. B., Franz, M., Sampson, L., Hennekens, C. H., & Manson, J. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1455 · Cited by 1,166 · cited 1×
“Some evidence from epidemiological studies suggests that a low-GI diet may be associated with a decreased risk for gestational diabetes mellitus (45), myocardial infarction (46), liver steatosis (47), and breast cancer (48).”
BackgroundNPY/AgRP Neurons Are Essential for Feeding in Adult Mice but Can Be Ablated in Neonates
Luquet, S., Perez, F. A., Hnasko, T. S., & Palmiter, R. D. (2005) · Science · doi:10.1126/science.1115524 · Cited by 1,125 · cited 1×
“Ablation of AgRP neurons leads to a cessation of food intake and death (117,118).”
BackgroundConserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity
Liou, A. P., Paziuk, M., Luevano, J.-M., Machineni, S., Turnbaugh, P. J., & Kaplan, L. M. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005687 · Cited by 1,007 · cited 4×
“Importantly, the transfer of post-RYGB microbiota into germfree animal models results in weight loss and reduced fat mass (88).”
BackgroundInfluentialFXR is a molecular target for the effects of vertical sleeve gastrectomy
Ryan, K. K., Tremaroli, V., Clemmensen, C., Kovatcheva-Datchary, P., Myronovych, A., Karns, R., Wilson-Pérez, H. E., Sandoval, D. A., Kohli, R., Bäckhed, F., et al. (2014) · Nature · doi:10.1038/nature13135 · Cited by 931 · cited 2×
“In FXR knockout mice, VSG loses its capacity to lower weight and improve glucose control, suggesting bile acids and FXR activation may be one mechanism by which VSG exerts its beneficial effects (80).”
BackgroundSelf-citationUsing Internet technology to deliver a behavioral weight loss program
Tate, D. F. (2001) · JAMA · doi:10.1001/jama.285.9.1172 · Cited by 925 · cited 1×
“Internet-based weight-loss programs that provide structure and repeated contact result in significant weight loss (31).”
BackgroundMulticenter, placebo-controlled trial of lorcaserin for weight management.
Smith, S. R., Weissman, N. J., Anderson, C. M., Sanchez, M., Chuang, E., Stubbe, S., Bays, H., & Shanahan, W. R. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909809 · Cited by 911 · cited 1×
“A pivotal phase three trial, Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM), found sustained weight loss and cardiometabolic benefits after 2 years; at 1 year, half of the participants achieved greater than 5% weight loss and 20% achieved greater than 10% weight loss versus placeb…”
BackgroundSelf-citationStevens, V. J., Obarzanek, E., Cook, N. R., Lee, I.-M., Appel, L. J., Smith West, D., Milas, N. C., Mattfeldt-Beman, M., Belden, L., Bragg, C., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-1-200101020-00007 · Cited by 886
Diets with high or low protein content and glycemic index for weight-loss maintenance
Larsen, T. M., Dalskov, S.-M., van Baak, M., Jebb, S. A., Papadaki, A., Pfeiffer, A. F. H., Martinez, J. A., Handjieva-Darlenska, T., Kunešová, M., Pihlsgård, M., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007137 · Cited by 843
on behalf of the NN8022-1923 Investigators, Wadden, T. A., Hollander, P., Klein, S., Niswender, K., Woo, V, Hale, P. M., & Aronne, L. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.120 · Cited by 842
Eight-year weight losses with an intensive lifestyle intervention: The look AHEAD study
The Look AHEAD Research Group (2014) · Obesity · doi:10.1002/oby.20662 · Cited by 842
Agouti-related peptide–expressing neurons are mandatory for feeding
Gropp, E., Shanabrough, M., Borok, E., Xu, A. W., Janoschek, R., Buch, T., Plum, L., Balthasar, N., Hampel, B., Waisman, A., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1548 · Cited by 798 · cited 1×
“Ablation of AgRP neurons leads to a cessation of food intake and death (117,118).”
BackgroundRandomized Trial of Lifestyle Modification and Pharmacotherapy for Obesity
Wadden, T. A., Berkowitz, R. I., Womble, L. G., Sarwer, D. B., Phelan, S., Cato, R. K., Hesson, L. A., Osei, S. Y., Kaplan, R., & Stunkard, A. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050156 · Cited by 794 · cited 1×
“Combining lifestyle modification with weight-loss medications, including GLP-1 receptor agonists, may give better results in humans (104,105).”
BackgroundAssociation of an intensive lifestyle intervention with remission of type 2 diabetes
Gregg, E. W., Chen, H., Wagenknecht, L. E., Clark, J. M., Delahanty, L. M., Bantle, J., Pownall, H. J., Johnson, K. C., Safford, M. M., Kitabchi, A. E., et al. (2012) · JAMA · doi:10.1001/jama.2012.67929 · Cited by 752
PPARγ agonists Induce a White-to-Brown Fat Conversion through Stabilization of PRDM16 Protein
Ohno, H., Shinoda, K., Spiegelman, B. M., & Kajimura, S. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.019 · Cited by 747 · cited 1×
“Thiazolidinediones (TZDs), such as rosiglitazone, induce “browning” in white fat, as indicated by an increase in uncoupling protein 1 (UCP1), a marker of brown fat, both in vitro and in vivo (112,113).”
BackgroundInsulin Action in AgRP-Expressing Neurons Is Required for Suppression of Hepatic Glucose Production
Könner, A. C., Janoschek, R., Plum, L., Jordan, S. D., Rother, E., Ma, X., Xu, C., Enriori, P., Hampel, B., Barsh, G. S., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.004 · Cited by 695 · cited 1×
“Paradoxically, the ablation of leptin (120) or insulin receptors (121) in AgRP neurons does not alter food intake in mice.”
BackgroundA proposed clinical staging system for obesity
Sharma, A. M., & Kushner, R. F. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.2 · Cited by 687 · cited 1×
“the Edmonton Obesity Staging System, a tool that divides obesity into five stages (0–4), based on the extent of obesity-related medical, mental, and functional limitations, that can help health care providers determine when to treat obesity patients with pharmacotherapy (92).”
MethodTate, D. F., Jackvony, E. H., & Wing, R. R. (2003) · JAMA · doi:10.1001/jama.289.14.1833 · Cited by 666 · cited 1×
“The addition of e-coaching, delivered in an automated format or by a human correspondent, further enhances the benefits of an Internet-based program (32,33).”
BackgroundNohr, E. A., Vaeth, M., Baker, J. L., Sørensen, T. I., Olsen, J., & Rasmussen, K. M. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.6.1750 · Cited by 649 · cited 1×
“Maternal weight gain during pregnancy has been correlated with higher birth weights, and mothers are likely to retain excess weight after pregnancy (4).”
BackgroundA new glucagon and GLP-1 co-agonist eliminates obesity in rodents
Day, J. W., Ottaway, N., Patterson, J. T., Gelfanov, V., Smiley, D., Gidda, J., Findeisen, H., Bruemmer, D., Drucker, D. J., Chaudhary, N., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.209 · Cited by 641
Transcriptional Control of Adipose Lipid Handling by IRF4
Eguchi, J., Wang, X., Yu, S., Kershaw, E. E., Chiu, P. C., Dushay, J., Estall, J. L., Klein, U., Maratos-Flier, E., & Rosen, E. D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.005 · Cited by 606 · cited 3×
“IRF4 is nutritionally regulated, with higher expression in the postfasting state than in the prefasting state (116).”
BackgroundInfluentialRosenbaum, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25977 · Cited by 575 · cited 2×
“The hormone leptin, for example, is not an effective weight-loss medication in humans, even at very high doses (111), but can normalize energy expenditure and ingestive behaviors at very low doses in weight-reduced humans (53).”
BackgroundGoodpaster, B. H., DeLany, J. P., Otto, A. D., Kuller, L., Vockley, J., South-Paul, J. E., Thomas, S. B., Brown, J., McTigue, K., Hames, K. C., et al. (2010) · JAMA · doi:10.1001/jama.2010.1505 · Cited by 558 · cited 1×
“Adding exercise to a weight-loss program can increase weight loss (55,56) and mitigate weightloss–related reductions in muscle fiber size (57).”
BackgroundPerinatal risk factors for childhood obesity and metabolic dysregulation
Catalano, P. M., Farrell, K., Thomas, A., Huston-Presley, L., Mencin, P., de Mouzon, S. H., & Amini, S. B. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27416 · Cited by 553
van Can, J., Sloth, B., Jensen, C. B., Flint, A., Blaak, E. E., & Saris, W. H. M. (2014) · International Journal of Obesity · doi:10.1038/ijo.2013.162 · Cited by 537 · cited 1×
“Liraglutide, a GLP-1 receptor agonist that has been available as a diabetes medication since 2010, also has effects on satiety and food intake (95).”
BackgroundO'Neil, P. M., Smith, S. R., Weissman, N. J., Fidler, M. C., Sanchez, M., Zhang, J., Raether, B., Anderson, C. M., & Shanahan, W. R. (2012) · Obesity · doi:10.1038/oby.2012.66 · Cited by 530
Self-citationComparative Epigenomic Analysis of Murine and Human Adipogenesis
Mikkelsen, T. S., Xu, Z., Zhang, X., Wang, L., Gimble, J. M., Lander, E. S., & Rosen, E. D. (2010) · Cell · doi:10.1016/j.cell.2010.09.006 · Cited by 526 · cited 2×
“By analyzing genome-wide histone modifications in mouse and human cells undergoing differentiation into adipocytes at multiple time points, researchers identified two regulators of adipogenesis: promyelocytic leukemia zinc finger protein (PLZF) and serum response factor (SRF) (115).”
BackgroundSimoneau, J., Veerkamp, J. H., Turcotte, L. P., & Kelley, D. E. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.2051 · Cited by 491 · cited 1×
“Exercise also increases fatty acid utilization by human skeletal muscle (58) and increases brown fat in mice (59), factors that may account for some of the benefits of exercise, as well as the link between exercise and weight maintenance.”
BackgroundBiology's response to dieting: the impetus for weight regain
MacLean, P. S., Bergouignan, A., Cornier, M.-A., & Jackman, M. R. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00755.2010 · Cited by 446 · cited 1×
“These changes include a decrease in salience of satiety signals, an increase in salience of hunger signals, and an increase in metabolic efficiency (37).”
BackgroundForkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake
Kitamura, T., Feng, Y., Ido Kitamura, Y., Chua, S. C., Xu, A. W., Barsh, G. S., Rossetti, L., & Accili, D. (2006) · Nature Medicine · doi:10.1038/nm1392 · Cited by 446 · cited 2×
“In support of this idea, mice with knockout of FoxO1 in AgRP neurons display reduced food intake, protection from weight gain from a highfat diet, and improved glucose homeostasis (122).”
BackgroundTrends in the Incidence of Coronary Heart Disease and Changes in Diet and Lifestyle in Women
Hu, F. B., Stampfer, M. J., Manson, J. E., Grodstein, F., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008243430802 · Cited by 437
Roth, J. D., Roland, B. L., Cole, R. L., Trevaskis, J. L., Weyer, C., Koda, J. E., Anderson, C. M., Parkes, D. G., & Baron, A. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706473105 · Cited by 436
Tate, D. F., Jackvony, E. H., & Wing, R. R. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1620 · Cited by 427
Bariatric Surgery Versus Intensive Medical Therapy in Obese Patients With Diabetes
Schauer, P. R., Kashyap, S. R., Wolski, K., Brethauer, S. A., Kirwan, J. P., Pothier, C. E., Thomas, S., Abood, B., Nissen, S. E., & Bhatt, D. L. (2013) · Survey of Anesthesiology · doi:10.1097/sa.0b013e31827f316e · Cited by 410
Targeting Epigenetic Readers in Cancer
Dawson, M. A., Kouzarides, T., & Huntly, B. J. P. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1112635 · Cited by 397 · cited 1×
“All of these alterations influence the expression levels of genes (114).”
BackgroundTreatment of Pediatric Obesity: A Systematic Review and Meta-Analysis of Randomized Trials
McGovern, L., Johnson, J. N., Paulo, R., Hettinger, A., Singhal, V., Kamath, C., Erwin, P. J., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2409 · Cited by 386
Long-term weight loss maintenance in the United States
Kraschnewski, J. L., Boan, J., Esposito, J., Sherwood, N. E., Lehman, E. B., Kephart, D. K., & Sciamanna, C. N. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.94 · Cited by 381 · cited 1×
“2), although it should be noted that around 15–20% of people maintain at least 10% of weight loss over the long term (35,36).”
BackgroundDietary Fiber Intake, Dietary Glycemic Load, and the Risk for Gestational Diabetes Mellitus
Zhang, C., Liu, S., Solomon, C. G., & Hu, F. B. (2006) · Diabetes Care · doi:10.2337/dc06-0266 · Cited by 378
Wilfley, D. E., Tibbs, T. L., Van Buren, D., Reach, K. P., Walker, M. S., & Epstein, L. H. (2007) · Health Psychology · doi:10.1037/0278-6133.26.5.521 · Cited by 362 · cited 1×
“Family-based interventions that take external factors into account can produce significant treatment effects in the overweight pediatric population (16).”
BackgroundPeripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
Tam, J., Cinar, R., Liu, J., Godlewski, G., Wesley, D., Jourdan, T., Szanda, G., Mukhopadhyay, B., Chedester, L., Liow, J.-S., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.002 · Cited by 356 · cited 2×
“The mechanisms of action for peripherally acting cannabinoid compounds are under investigation and may include modulation of leptin signaling (97), activation of brown adipose tissue (98), and effects on the sympathetic nervous system (99).”
Backgroundvan de Wall, E., Leshan, R., Xu, A. W., Balthasar, N., Coppari, R., Liu, S. M., Jo, Y. H., MacKenzie, R. G., Allison, D. B., Dun, N. J., et al. (2008) · Endocrinology · doi:10.1210/en.2007-1132 · Cited by 338 · cited 1×
“Paradoxically, the ablation of leptin (120) or insulin receptors (121) in AgRP neurons does not alter food intake in mice.”
BackgroundTargeted estrogen delivery reverses the metabolic syndrome
Finan, B., Yang, B., Ottaway, N., Stemmer, K., Müller, T. D., Yi, C.-X., Habegger, K., Schriever, S. C., García-Cáceres, C., Kabra, D. G., et al. (2012) · Nature Medicine · doi:10.1038/nm.3009 · Cited by 337
Self-citationRavussin, E., Smith, S. R., Mitchell, J. A., Shringarpure, R., Shan, K., Maier, H., Koda, J. E., & Weyer, C. (2009) · Obesity · doi:10.1038/oby.2009.184 · Cited by 332 · cited 1×
“Other combinations have been explored in humans, such as pramlintide/phentermine (108) and pramlintide/metreleptin (in subjects with BMI ,35 kg/m(2)) (109), however, development programs on these combinations have been discontinued due to commercial considerations.”
BackgroundSelf-citationEffects of dietary glycaemic index on adiposity, glucose homoeostasis, and plasma lipids in animals
Pawlak, D. B., Kushner, J. A., & Ludwig, D. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16937-7 · Cited by 325 · cited 1×
“Despite having similar average body weights, rodents fed a high-GI diet have more body fat and less lean mass than those on a low-GI diet (43).”
BackgroundExercise as an adjunct to weight loss and maintenance in moderately obese subjects
Pavlou, K. N., Krey, S., & Steffee, W. P. (1989) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/49.5.1115 · Cited by 321 · cited 1×
“For weight loss, diet restriction may be the most important component, and then as one moves into the weight-maintenance phase of obesity treatment, physical activity becomes an important factor (50).”
BackgroundThe LiP (Lifestyle in Pregnancy) Study
Vinter, C. A., Jensen, D. M., Ovesen, P., Beck-Nielsen, H., & Jørgensen, J. S. (2011) · Diabetes Care · doi:10.2337/dc11-1150 · Cited by 309 · cited 1×
“weight gain with lifestyle intervention did not result in improved obstetric outcomes relative to a control group (5).”
BackgroundWilson-Pérez, H. E., Chambers, A. P., Ryan, K. K., Li, B., Sandoval, D. A., Stoffers, D., Drucker, D. J., Pérez-Tilve, D., & Seeley, R. J. (2013) · Diabetes · doi:10.2337/db12-1498 · Cited by 291 · cited 1×
“receptor is a key mediator of these VSG benefits (77,78).”
BackgroundSelf-citationEffects of experimental weight perturbation on skeletal muscle work efficiency in human subjects
Rosenbaum, M., Vandenborne, K., Goldsmith, R., Simoneau, J.-A., Heymsfield, S., Joanisse, D. R., Hirsch, J., Murphy, E., Matthews, D., Segal, K. R., et al. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00474.2002 · Cited by 255 · cited 1×
“Figure 3—Relationship between changes in nonresting energy expenditure (NREE) and changes in muscle gross mechanical efficiency (GME) after weight change (51).”
BackgroundSelf-citationResch, K. (2008) · PubMed · Cited by 202
Shah, K., Stufflebam, A., Hilton, T. N., Sinacore, D. R., Klein, S., & Villareal, D. T. (2009) · Obesity · doi:10.1038/oby.2009.126 · Cited by 194
Antiobesity Pharmacotherapy: New Drugs and Emerging Targets
Kim, G. W., Lin, J. E., Blomain, E. S., & Waldman, S. A. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.204 · Cited by 191 · cited 1×
“All of these agents are associated with a mean weight loss of around 5–10% (89) versus placebo control.”
BackgroundMyronovych, A., Kirby, M., Ryan, K. K., Zhang, W., Jha, P., Setchell, K. D., Dexheimer, P. J., Aronow, B., Seeley, R. J., & Kohli, R. (2014) · Obesity · doi:10.1002/oby.20548 · Cited by 182
Self-citationGLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents
Ye, J., Hao, Z., Mumphrey, M. B., Townsend, R. L., Patterson, L. M., Stylopoulos, N., Münzberg, H., Morrison, C. D., Drucker, D. J., & Berthoud, H.-R. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00491.2013 · Cited by 174 · cited 2×
“However, in rat studies, blocking GLP-1 does not affect the response to RYGB (84).”
BackgroundSmith, S. R., Aronne, L. J., Burns, C. M., Kesty, N. C., Halseth, A. E., & Weyer, C. (2008) · Diabetes Care · doi:10.2337/dc08-0029 · Cited by 172 · cited 1×
“Pramlintide, an amylin analog that is currently approved for the treatment of diabetes, also reduces food intake in obese subjects (93), and in studies examining its efficacy for weight reduction, pramlintide led to sustained weight loss over a year (94).”
BackgroundSelf-citationThe Effects of Vertical Sleeve Gastrectomy in Rodents Are Ghrelin Independent
Chambers, A. P., Kirchner, H., Wilson, H., Willency, J. A., Hale, J. E., Gaylinn, B. D., Thorner, M. O., Pfluger, P. T., Gutierrez, J. A., Tschöp, M. H., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.09.009 · Cited by 168
Self-citationMelanocortin-4 Receptor Signaling Is Required for Weight Loss after Gastric Bypass Surgery
Hatoum, I. J., Stylopoulos, N., Vanhoose, A. M., Boyd, K. L., Yin, D., Ellacott, K. L. J., Li, L., Blaszczyk, K., Keogh, J. M., Cone, R. D., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3432 · Cited by 168 · cited 1×
“Interestingly, the effects of bariatric surgery on weight loss appear to be dependent on MC4R in homozygous knockout animal models (71) and in humans with complete MC4R deficiency (72).”
BackgroundDiet and Gastrointestinal Bypass–Induced Weight Loss
Chandarana, K., Gelegen, Ç., Karra, E., Choudhury, A. I., Drew, M. E., Fauveau, V., Viollet, B., Andréelli, F., Withers, D. J., & Batterham, R. L. (2011) · Diabetes · doi:10.2337/db10-0566 · Cited by 165 · cited 1×
“Peptide YY knockout mice do not significantly decrease body weight after bypass surgery (85), suggesting that the hormone has some role in RYGB benefits.”
BackgroundOzanne, S. E., Lewis, R. M., Jennings, B. J., & Hales, C. N. (2004) · Clinical Science · doi:10.1042/cs20030278 · Cited by 163 · cited 1×
“In one study (1), researchers fed gestating mice either a 20% protein diet (normal control diet) or an 8% protein diet (low-protein diet).”
BackgroundAgRP neurons regulate development of dopamine neuronal plasticity and nonfood-associated behaviors
Dietrich, M. O., Bober, J., Ferreira, J. G., Tellez, L. A., Mineur, Y. S., Souza, D. O., Gao, X.-B., Picciotto, M. R., Araújo, I., Liu, Z.-W., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3147 · Cited by 158 · cited 2×
“Horvath and colleagues (119) found that AgRP neurons regulate reward circuitry more generally, affecting dopamine neuronal plasticity.”
BackgroundMüller, T. D., Sullivan, L. M., Habegger, K., Yi, C., Kabra, D., Grant, E., Ottaway, N., Krishna, R., Holland, J., Hembree, J., et al. (2012) · Journal of Peptide Science · doi:10.1002/psc.2408 · Cited by 156
The role of free-living daily walking in human weight gain and obesity
Levine, J. A., McCrady, S. K., Lanningham-Foster, L. M., Kane, P. H., Foster, R. C., & Manohar, C. U. (2008) · Diabetes · doi:10.2337/db07-0815 · Cited by 148 · cited 1×
“In people, reduction of NEAT due to an increasingly sedentary lifestyle may be associated with increasing obesity (63).”
BackgroundChomentowski, P., Dube, J. J., Amati, F., Stefanovic-Racic, M., Zhu, S., Toledo, F. G. S., & Goodpaster, B. H. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glp007 · Cited by 137 · cited 1×
“Adding exercise to a weight-loss program can increase weight loss (55,56) and mitigate weightloss–related reductions in muscle fiber size (57).”
BackgroundBellocchio, L., Gómez, E. S., Quarta, C., Metna‐Laurent, M., Cardinal, P., Binder, E., Cannich, A., Delamarre, A., Häring, M., Martín‐Fontecha, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218573110 · Cited by 137 · cited 1×
“The mechanisms of action for peripherally acting cannabinoid compounds are under investigation and may include modulation of leptin signaling (97), activation of brown adipose tissue (98), and effects on the sympathetic nervous system (99).”
BackgroundThe effect of vertical sleeve gastrectomy on food choice in rats
Wilson, H., Chambers, A. P., Sandoval, D. A., Stefater, M. A., Woods, S. C., Benoit, S. C., & Seeley, R. J. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.18 · Cited by 136
Self-citationMacLean, P. S., HIGGINS, J. A., Jackman, M. R., Johnson, G. C., Fleming‐Elder, B. K., Wyatt, H. R., Melanson, E. L., & Hill, J. O. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00810.2005 · Cited by 135
Smith, S. R., Blundell, J. E., Burns, C. M., Ellero, C., Schroeder, B. E., Kesty, N. C., Chen, K. S., Halseth, A. E., Lush, C. W., & Weyer, C. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00217.2007 · Cited by 134 · cited 1×
“Pramlintide, an amylin analog that is currently approved for the treatment of diabetes, also reduces food intake in obese subjects (93), and in studies examining its efficacy for weight reduction, pramlintide led to sustained weight loss over a year (94).”
BackgroundSelf-citationDietary glycemic index and liver steatosis
Valtueña, S., Pellegrini, N., Ardigò, D., Rio, D. D., Numeroso, F., Scazzina, F., Monti, L. D., Zavaroni, I., & Brighenti, F. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.136 · Cited by 129 · cited 1×
“Some evidence from epidemiological studies suggests that a low-GI diet may be associated with a decreased risk for gestational diabetes mellitus (45), myocardial infarction (46), liver steatosis (47), and breast cancer (48).”
BackgroundRing, L. E., & Zeltser, L. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41985 · Cited by 127 · cited 4×
“To help define how set points are programmed, Ring and Zeltser (11) studied a leptin receptor knockout mouse, which exhibits early-onset hyperphagia and obesity that stabilizes with maturity.”
BackgroundInfluentialPhentermine/Topiramate for the Treatment of Obesity
Smith, S. M., Meyer, M., & Trinkley, K. E. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r501 · Cited by 122 · cited 1×
“The next question is can medication combinations with complementary mechanisms recreate the benefits of adding lifestyle modifications to a weight-loss drug? Promising combinations include the recently approved bupropion/ naltrexone (106) and phentermine/topiramate (107).”
BackgroundSelf-citationSilvera, S. A. N., Jain, M. G., Howe, G. R., Miller, A. B., & Rohan, T. E. (2004) · International Journal of Cancer · doi:10.1002/ijc.20796 · Cited by 121 · cited 1×
“Some evidence from epidemiological studies suggests that a low-GI diet may be associated with a decreased risk for gestational diabetes mellitus (45), myocardial infarction (46), liver steatosis (47), and breast cancer (48).”
BackgroundLowe, M., Miller‐Kovach, K., & Phelan, S. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801521 · Cited by 118 · cited 1×
“2), although it should be noted that around 15–20% of people maintain at least 10% of weight loss over the long term (35,36).”
BackgroundBoon, M. R., Kooijman, S., van Dam, A. D., Pelgrom, L. R., Berbée, J. F. P., Visseren, C. A. R., Aggele, R. C., van den Hoek, A. M., Sips, H. C. M., Lombès, M., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-247643 · Cited by 112 · cited 1×
“The mechanisms of action for peripherally acting cannabinoid compounds are under investigation and may include modulation of leptin signaling (97), activation of brown adipose tissue (98), and effects on the sympathetic nervous system (99).”
BackgroundPatterson, C. M., Bouret, S. G., Dunn-Meynell, A. A., & Levin, B. E. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90859.2008 · Cited by 106 · cited 1×
“by reducing central leptin resistance (60,61).”
Bessler, M., Daud, A., Kim, T., & DiGiorgi, M. (2007) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2007.01.010 · Cited by 105 · cited 1×
“A comparison between RYGB and LAGB showed significant variation in patient weight loss, with greater variation observed in the group with gastric banding (68).”
ResultAronne, L. J., Halseth, A. E., Burns, C. M., Miller, S., & Shen, L. Z. (2010) · Obesity · doi:10.1038/oby.2009.478 · Cited by 102 · cited 1×
“Other combinations have been explored in humans, such as pramlintide/phentermine (108) and pramlintide/metreleptin (in subjects with BMI ,35 kg/m(2)) (109), however, development programs on these combinations have been discontinued due to commercial considerations.”
BackgroundThe Effect of Physical Activity on 18‐Month Weight Change in Overweight Adults
Jakicic, J. M., Otto, A. D., Lang, W., Semler, L., Winters, C., Polzien, K. M., & Mohr, K. I. (2010) · Obesity · doi:10.1038/oby.2010.122 · Cited by 101 · cited 1×
“Adding exercise to a weight-loss program can increase weight loss (55,56) and mitigate weightloss–related reductions in muscle fiber size (57).”
BackgroundVoluntary Exercise Improves High-Fat Diet-Induced Leptin Resistance Independent of Adiposity
Carhuatanta, K. A. K., Demuro, G., Tschöp, M. H., Pfluger, P. T., Benoit, S. C., & Obici, S. (2011) · Endocrinology · doi:10.1210/en.2010-1340 · Cited by 95 · cited 1×
“by reducing central leptin resistance (60,61).”
Jackman, M. R., Steig, A. J., HIGGINS, J. A., Johnson, G. C., Fleming‐Elder, B. K., Bessesen, D. H., & MacLean, P. S. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00808.2007 · Cited by 94 · cited 1×
“during weight loss in rats, consistent with promoting the ability of the cells to take up nutrients (38,39).”
BackgroundThree weeks of early-onset exercise prolongs obesity resistance in DIO rats after exercise cessation
Patterson, C. M., Dunn-Meynell, A. A., & Levin, B. E. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00661.2007 · Cited by 93
Valette, M., Poitou, C., Beyec, J. L., Bouillot, J., Clément, K., & Czernichow, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048221 · Cited by 93 · cited 1×
“However, patient heterozygosity for obesity-producing MC4R mutations does not affect the response to bariatric surgery (73,74).”
BackgroundRegular exercise attenuates the metabolic drive to regain weight after long-term weight loss
MacLean, P. S., HIGGINS, J. A., Wyatt, H. R., Melanson, E. L., Johnson, G. C., Jackman, M. R., Giles, E. D., Brown, I. E., & Hill, J. O. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00192.2009 · Cited by 93 · cited 1×
“Exercise prevents adipocyte hyperplasia in animals (40), offering one mechanism by which physical activity may attenuate weight regain.”
BackgroundObesity surgery and gut–brain communication
Berthoud, H., Shin, A. C., & Zheng, H. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.01.023 · Cited by 92 · cited 1×
“The mechanisms for these metabolic improvements are poorly understood and apparently involve changes in brain, gut, and peripheral signaling pathways (81).”
BackgroundManohar, C., Levine, J. A., Nandy, D. K., Saad, A., Dalla Man, C., McCrady-Spitzer, S. K., Basu, R., Cobelli, C., Carter, R. E., Basu, A., et al. (2012) · Diabetes Care · doi:10.2337/dc11-2381 · Cited by 89 · cited 1×
“Other studies suggest that NEAT may have effects on blood glucose as well; as anticipated based on the wellrecognized effects of muscle contraction on glucose uptake (independent of insulin), walking after a meal was associated with significant reductions in postprandial glucose excursions in studies of patients with…”
BackgroundWeight-loss with low or high carbohydrate diet?
Golay, A., Eigenheer, C., Morel, Y., Kujawski, P., Lehmann, T. N., & Tonnac, N. D. (1996) · PubMed · Cited by 86
Weight Loss after Roux-en-Y Gastric Bypass in Obese Patients Heterozygous for MC4R Mutations
Aslan, I. R., Campos, G. M., Calton, M. A., Evans, D. S., Merriman, R. B., & Vaisse, C. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0295-8 · Cited by 82 · cited 1×
“However, patient heterozygosity for obesity-producing MC4R mutations does not affect the response to bariatric surgery (73,74).”
BackgroundBariatric surgery in a patient with complete MC4R deficiency
Aslan, I. R., Ranadive, S. A., Ersoy, B. A., Rogers, S., Lustig, R. H., & Vaisse, C. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.168 · Cited by 76 · cited 1×
“Interestingly, the effects of bariatric surgery on weight loss appear to be dependent on MC4R in homozygous knockout animal models (71) and in humans with complete MC4R deficiency (72).”
BackgroundHaskell‐Luevano, C., Schaub, J. W., Andreasen, A., Haskell, K. R., Moore, M. C., Koerper, L. M., Rouzaud, F., Baker, H. V., Millard, W. J., Walter, G., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-109686 · Cited by 72 · cited 1×
“Wheel running lowered body and fat mass in MC4R knockout mice (62) and rats; however, voluntary wheel running and the expression of DeltaFosB, a protein associated with addiction, in nucleus accumbens (NAc) neurons were reduced in these animals (J.”
BackgroundShin, A. C., Zheng, H., & Berthoud, H. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e31823e71b7 · Cited by 71 · cited 1×
“The vagus nerve does not appear to be relevant (86), nor is ghrelin required for VSG to be effective in mice (77).”
BackgroundEquivalent weight loss for weight management programs delivered by phone and clinic
Donnelly, J. E., Goetz, J. R., Gibson, C., Sullivan, D. K., Lee, R. H., SMITH, B. K., Lambourne, K., Mayo, M. S., Hunt, S. L., Lee, J. H., et al. (2013) · Obesity · doi:10.1002/oby.20334 · Cited by 63 · cited 1×
“Phone-based interventions may provide a convenient approach to weight loss and weight maintenance, with efficacy in some studies matching in-person interventions (30).”
BackgroundInhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity
Joharapurkar, A. A., Jain, M. R., & Dhanesha, N. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s56924 · Cited by 63 · cited 2×
“The mechanisms of action for the weight effects of beloranib are not well understood, however, they appear to be related not to angiogenesis but rather to the suppression of sterol regulatory element–binding protein activity and the attenuation of signaling through extracellular signal–regulated kinase pathways, resul…”
BackgroundGoldschmidt, A. B., Wilfley, D. E., Paluch, R. A., Roemmich, J. N., & Epstein, L. H. (2012) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2013.416 · Cited by 62
Obesity is a surgical disease: overview of obesity and bariatric surgery
O’Brien, P. E., Dixon, J. B., & Brown, W. A. (2004) · ANZ Journal of Surgery · doi:10.1111/j.1445-2197.2004.03014.x · Cited by 62 · cited 1×
“An Australian study found that RYGB results in more rapid weight loss than LAGB, but that weight loss is similar over the long term (69).”
BackgroundIs ghrelin a signal for the development of metabolic systems?
Grove, K. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27211 · Cited by 60 · cited 1×
“In normal rodent development, leptin surges shortly after birth and then declines, while ghrelin levels, low at first, rise as leptin levels decline (7).”
BackgroundEffects of weight loss and leptin on skeletal muscle in human subjects
Baldwin, K. M., Joanisse, D. R., Haddad, F., Goldsmith, R. L., Gallagher, D., Pavlovich, K. H., Shamoon, E. L., Leibel, R. L., & Rosenbaum, M. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00397.2011 · Cited by 58
Self-citationDaily Intraparaventricular Orexin‐A Treatment Induces Weight Loss in Rats
Novak, C. M., & Levine, J. A. (2009) · Obesity · doi:10.1038/oby.2009.91 · Cited by 53 · cited 1×
“Biochemical manipulation of NEAT may also be possible; the neuropeptide orexin increases NEAT and reduces weight in rats (65).”
BackgroundFoster, G. D., Wadden, T. A., Lagrotte, C. A., Veur, S. S. V., Hesson, L. A., Homko, C. J., Maschak-Carey, B. J., Barbor, N. R., Bailer, B. A., Diewald, L. K., et al. (2013) · Nutrition and Diabetes · doi:10.1038/nutd.2013.3 · Cited by 52 · cited 1×
“Several studies have demonstrated that meal replacements enhance both initial and long-term weight loss (25,26).”
BackgroundCaloric Restriction Chronically Impairs Metabolic Programming in Mice
Kirchner, H., Hofmann, S. M., Fischer‐Rosinsky, A., Hembree, J., Abplanalp, W. A., Ottaway, N., Donelan, E. M., Krishna, R., Woods, S. C., Müller, T. D., et al. (2012) · Diabetes · doi:10.2337/db11-1621 · Cited by 47
Buyken, A. E., Dettmann, W., Kersting, M., & Kroke, A. (2005) · British Journal Of Nutrition · doi:10.1079/bjn20051537 · Cited by 42 · cited 1×
“, the percentage of calories from fat has decreased, while the dietary glycemic index (GI)/glycemic load (GL) has increased (41,42).”
BackgroundThe threshold shift paradigm of obesity: evidence from surgically induced weight loss
Ferrannini, E., Rosenbaum, M., & Leibel, R. L. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.090167 · Cited by 32 · cited 1×
“Though surgery may not entirely defeat a preprogrammed body weight set point (83), these observations suggest that gut hormones play a role in the physiological responses to bariatric surgery.”
BackgroundSelf-citationLeptin-Independent Programming of Adult Body Weight and Adiposity in Mice
Cottrell, E. C., Martin‐Gronert, M. S., Fernandez‐Twinn, D. S., Luan, J., Berends, L. M., & Ozanne, S. E. (2011) · Endocrinology · doi:10.1210/en.2010-0911 · Cited by 31 · cited 1×
“The results were similar in leptin-deficient mice, suggesting that the effect was leptin independent (2).”
THE NATIONAL WEIGHT CONTROL REGISTRY
Thomas, J. G., Bond, D. S., Hill, J. O., & Wing, R. R. (2011) · ACSMʼs Health & Fitness Journal · doi:10.1249/fit.0b013e31820b72b5 · Cited by 24 · cited 1×
“Data from the National Weight Control Registry, which includes people who have lost at least 30 pounds and kept it off for a year or more, suggest that long-term weight maintenance is associated with frequent self-weighing, high levels of physical activity, limited television viewing, and a low-calorie/low-fat diet (4…”
MethodObesity surgery: happy with less or eternally hungry?
Shin, A. C., & Berthoud, H. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.11.009 · Cited by 21
Effects of a novel MC4R agonist on maintenance of reduced body weight in diet‐induced obese mice
Skowronski, A. A., Morabito, M. V., Mueller, B. R., Lee, S., Hjorth, S., Lehmann, A., Watanabe, K., Zeltser, L. M., Ravussin, Y., ROSENBAUM, M. S., et al. (2013) · Obesity · doi:10.1002/oby.20678 · Cited by 18 · cited 1×
“The efficacy of drugs in the induction of weight loss and maintenance of reduced body weight may differ (110).”
BackgroundSelf-citationLong-term obesity levels in female OLETF rats following time-specific post-weaning food restriction
Schroeder, M., Gelber, V., Moran, T. H., & Weller, A. (2010) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.08.008 · Cited by 13
TRENDS IN THE INCIDENCE OF CORONARY HEART DISEASE AND CHANGES IN DIET AND LIFESTYLE IN WOMEN
Rank, F., Tampfer, M. E. J. S., Anson, E. M., Rodstein, F. R. G., Olditz, G. R. A. C., Peizer, F. R. E. S., & Illett, W. A. C. W. (2013) · Cited by 13
Research works printed but not linked: 1
- Elia, 1992, Organ and tissue contribution to metabolic rate, 61
Cited by
Mechanisms, Pathophysiology, and Management of Obesity
Heymsfield, S. B., & Wadden, T. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1514009 · Cited by 1,867
Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., Lingvay, I., Mosenzon, O., Rosenstock, J., Rubio, M. A., et al. (2021) · JAMA · doi:10.1001/jama.2021.3224 · Cited by 1,444
Wadden, T. A., Bailey, T. S., Billings, L. K., Davies, M., Frias, J. P., Koroleva, A., Lingvay, I., O’Neil, P. M., Rubino, D. M., Skovgaard, D., et al. (2021) · JAMA · doi:10.1001/jama.2021.1831 · Cited by 1,114
Anti-obesity drug discovery: advances and challenges
Müller, T. D., Blüher, M., Tschöp, M. H., & DiMarchi, R. D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00337-8 · Cited by 1,021
Carbone, S., Del Buono, M. G., Ozemek, C., & Lavie, C. J. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.08.004 · Cited by 327
Metadata
- Authors
- Leibel, R. L., Seeley, R. J., Darsow, T., Berg, E. G., Smith, S. R., & Ratner, R.
- Affiliations
- Columbia University (US)
- University of Michigan (US)
- American Diabetes Association (US)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Darsow, Tamara
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2015-06-17
- Volume
- 64
- Issue
- 7
- Pages
- 2299-2309
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W1948107585
- Cited by
- 52
- References
- 122
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 5 · 2020: 6 · 2019: 7 · 2018: 11 · 2017: 4 · 2016: 6 · 2015: 1
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- weight loss, weight regain, childhood obesity, fetal programming, birth weight, gestational factors, weight gain prevention, weight maintenance, behavioral weight management, physical activity, bariatric surgery, obesity pharmacotherapy, type 2 diabetes
- MeSH terms
- Forkhead Box Protein O1, Body Weight, Diabetes Mellitus, Type 2, Gastrectomy, Humans, Obesity, Weight Gain, Weight Loss, Exercise, Bariatric Surgery, Forkhead Transcription Factors, Agouti-Related Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.